HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.
Saved in:
| Title: | HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. |
|---|---|
| Authors: | Chang, Xu1 (AUTHOR), Li, Xinge2 (AUTHOR), Sun, Peng1 (AUTHOR), Li, Zhenfeng1 (AUTHOR), Sun, Pengfei3 (AUTHOR) drsunpengfei@sina.com, Ning, Shangkun4 (AUTHOR) ningskun@163.com |
| Source: | BMC Cancer. 4/16/2024, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
